Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

IL-1β inhibits human hair follicle growth.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

A new skin-whitening agent using a peptide from wheat is safe and effective at reducing skin pigmentation.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

BMS-470539 reduces skin fibrosis and inflammation.

Rosa rugosa extract promotes hair growth and could be a natural treatment for hair loss.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

D'orenone stops root hair growth by disrupting auxin transport, but adding auxin can reverse this.

IFN-γ production by CD4 T cells is crucial for causing alopecia areata.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Skin development in mammals is controlled by key proteins and signals from underlying cells, involving stem cells for maintenance and repair.

Blocking a protein called CXXC5 with a specific peptide can stimulate hair regrowth and new hair growth in wounds.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

Cyclosporin A promotes hair growth in mice and increases a protein linked to hair growth, but it may not work the same way in humans.

Deleting the CRIF1 gene in mice disrupts skin and hair formation, certain proteins affect hair growth, a new compound may improve skin and hair health, blood cell-derived stem cells can create skin-like structures, and hair follicle stem cells come from embryonic cells needing specific signals for development.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.